These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 27881620)

  • 1. Catching Fakes: New Markers of Urine Sample Validity and Invalidity.
    Goggin MM; Tann CM; Miller A; Nguyen A; Janis GC
    J Anal Toxicol; 2017 Mar; 41(2):121-126. PubMed ID: 27881620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specimen validity testing in urine drug monitoring of medications and illicit drugs: clinical implications.
    Kirsh KL; Christo PJ; Heit H; Steffel K; Passik SD
    J Opioid Manag; 2015; 11(1):53-9. PubMed ID: 25750165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic investigations of novel validity parameters in urine drug testing and prevalence of urine adulteration in a two-year cohort.
    Kluge J; Rentzsch L; Remane D; Peters FT; Wissenbach DK
    Drug Test Anal; 2018 Oct; 10(10):1536-1542. PubMed ID: 29956490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new automated assay for the detection of synthetic urine in drug testing.
    Silva F; Kaileh I; Hobbs GA
    Drug Test Anal; 2019 Jul; 11(7):926-930. PubMed ID: 30920168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adulteration of urine drug testing--an exaggerated cause of concern].
    Beck O; Bohlin M; Bragd F; Bragd J; Greitz O
    Lakartidningen; 2000 Feb; 97(7):703-6. PubMed ID: 10740378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Novel Markers for Specimen Validity Testing.
    Kyle PB; Kaur J
    Arch Pathol Lab Med; 2020 Feb; 144(2):168-171. PubMed ID: 31755779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Confirmation of the Department of Transportation criteria for a substituted urine specimen.
    Barbanel CS; Winkelman JW; Fischer GA; King AJ
    J Occup Environ Med; 2002 May; 44(5):407-16. PubMed ID: 12024686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characterization of human urine for specimen validity determination in workplace drug testing: a review.
    Cook JD; Caplan YH; LoDico CP; Bush DM
    J Anal Toxicol; 2000 Oct; 24(7):579-88. PubMed ID: 11043663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fluid load on human urine characteristics related to workplace drug testing.
    Chaturvedi AK; Sershon JL; Craft KJ; Cardona PS; Soper JW; Canfield DV; Dubowski KM; Whinnery JE; Leyva MJ; Aston CE; Blevins SM; Wright JE; Fraser AD; Kuntz DJ
    J Anal Toxicol; 2013; 37(1):5-10. PubMed ID: 23104711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can synthetic urine replace authentic urine to "beat" workplace drug testing?
    Kim VJ; Okano CK; Osborne CR; Frank DM; Meana CT; Castaneto MS
    Drug Test Anal; 2019 Feb; 11(2):331-335. PubMed ID: 30194711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dilution of Urine Followed by Adulteration in an Attempt to Deceive the Laboratory.
    Feldhammer M; Saitman A; Nguyen L; Milstid B
    J Anal Toxicol; 2019 Jan; 43(1):e7-e9. PubMed ID: 30192938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of freezing point depression osmolality for classifying random urine specimens defined as substituted under HHS/DOT criteria.
    Cook JD; Hannon MW; Vo T; Caplan YH
    J Anal Toxicol; 2002 Oct; 26(7):424-9. PubMed ID: 12422996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The defined HHS/DOT substituted urine criteria validated through a controlled hydration study.
    Edgell K; Caplan YH; Glass LR; Cook JD
    J Anal Toxicol; 2002 Oct; 26(7):419-23. PubMed ID: 12422995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choosing the right laboratory: a review of clinical and forensic toxicology services for urine drug testing in pain management.
    Reisfield GM; Goldberger BA; Bertholf RL
    J Opioid Manag; 2015; 11(1):37-44. PubMed ID: 25750163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine Creatinine Concentrations in Drug Monitoring Participants and Hospitalized Patients.
    Love SA; Seegmiller JC; Kloss J; Apple FS
    J Anal Toxicol; 2016 Oct; 40(8):659-662. PubMed ID: 27590035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Workplace drug testing on urine samples: evidence for improving efficacy of a first-level screening programme.
    Crespi V; Maio RC; Veronesi G; Gianfagna F; Taborelli S; Ferrario MM
    Med Lav; 2015 Sep; 106(5):374-85. PubMed ID: 26384263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on Urine Adulterants and Synthetic Urine Samples to Subvert Urine Drug Testing.
    Vikingsson S; Krauss ST; Winecker RE; Flegel RR; Hayes ED
    J Anal Toxicol; 2022 Aug; 46(7):697-704. PubMed ID: 35639619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of normal urine with a creatinine concentration under the cutoff of 20 mg/dL for specimen validity testing in a toxicology laboratory.
    Holden B; Guice EA
    J Forensic Sci; 2014 May; 59(3):806-10. PubMed ID: 24502684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of a four hour delay for urine samples stored without preservatives at room temperature for urinalysis.
    Veljkovic K; Rodríguez-Capote K; Bhayana V; Pickersgill R; Beattie J; Clark L; Kavsak PA
    Clin Biochem; 2012 Jul; 45(10-11):856-8. PubMed ID: 22548911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.